Case Number: No. 2021-00007823

Practice Area: Securities Fraud & Investor Protection

Case Status: Settled

Settlement Amount: Confidential

Court: Superior Court for the State of California, County of San Diego

Berger Montague settled a lawsuit against Chicago Title Co. on behalf of its individual clients who alleged they were victims in a more than $400 million liquor license lending Ponzi scheme engineered by Gina Champion-Cain through ANI Development. Following extensive proceedings and hard fought negotiations, Chicago Title agreed to pay 70% of Berger Montague’s clients’ out-of-pocket losses, which was greater than Chicago Title’s agreement to pay 65% of losses suffered by investors who filed individual cases in federal court. Michael Dell’Angelo, Barbara Podell, and Andrew Abramowitz of Berger Montague were responsible for this matter. The case was litigated in the Superior Court for the State of California, County of San Diego and captioned Allred, et al. v. Chicago Title Company, et al., No. 2021-00007823 (San Diego Sup. Ct.).

If you are an investor and have questions about a potential securities fraud lawsuit, or are seeking advice regarding potential commercial litigation, please contact Berger Montague.

About Berger Montague

Berger Montague is a national law firm focusing on complex civil litigation in federal and state courts throughout the United States. For over half a century, Berger Montague has played lead roles in consequential, precedent-setting cases and has recovered over $50 billion for its clients and the classes they have represented. Berger Montague is headquartered in Philadelphia and has offices in Chicago, Minneapolis, San Diego, San Francisco, Toronto, and Washington, D.C.

schedule a free consultation

"*" indicates required fields

By clicking SUBMIT you agree to our Terms of Use and Privacy Policy and you are providing express consent to receive communications from Berger Montague via calls, emails, and/or text messages.

On the Cutting Edge of the Profession

Legal Intelligencer